Delivering reliable patient access, experienced investigators, and efficient trial execution in the heart of San Diego, California.
Delivering reliable patient access, experienced investigators, and efficient trial execution in the heart of the Denver Metro Area.
Infinity Clinical Studies is a dedicated full-time clinical research facility located in San Diego, California, serving a diverse adult population across the greater San Diego region. Our multi-specialty team of board-certified physicians brings Phase II through IV experience across multiple therapeutic areas, giving sponsors and CROs a research-ready clinical research organization in San Diego they can count on.
As a proud member of ECN Clinical, Infinity operates under centralized SOPs, unified contracting, and network-wide quality standards, giving sponsors the consistency of a national network with the accountability of a dedicated local site.
Infinity Clinical Studies conducts clinical research across a focused range of therapeutic areas with particular strength in internal medicine clinical research, ophthalmology clinical research, endocrinology, cardiology, and pain management research in San Diego. Our investigators bring board-certified expertise to every study, ensuring genuine therapeutic specialization across every indication we pursue.
Our patient recruitment infrastructure combines technology, community relationships, and dedicated outreach to deliver consistent enrollment performance across every study we support.
Infinity Clinical Studies serves a diverse adult population across San Diego and Southern California. Our Camino Del Rio South location provides easy access for participants across the greater San Diego region, making clinical research recruitment in San Diego straightforward for both sponsors and patients.
Our San Diego location gives Infinity Clinical Studies access to one of California's most culturally rich and diverse communities. Our patient population reflects broad representation across White, Hispanic, Asian, and African American communities, helping sponsors meet FDA diversity requirements and build more inclusive development programs across every study we support.
Diversity in clinical research is a commitment to the communities we serve. Our sites are chosen and structured to reflect the communities they serve, ensuring every study benefits from genuine local representation, trust, and accessibility.
Our network capability deck or TA-specific one-pagers to share with your team.
Yes. Infinity Clinical Studies offers paid clinical research opportunities in San Diego and across Southern California. Compensation varies by study and will be explained clearly before you enroll. Study-related medical care and visits are always at no cost to participants.
Infinity Clinical Studies is located at 3703 Camino Del Rio South, Suite 100, San Diego, CA 92108, serving participants across a 40-mile catchment radius throughout the greater San Diego region and Southern California.
Infinity Clinical Studies is a CLIA-certified clinical research facility in California offering Phase II through IV capabilities. Our site includes onsite ECG, temperature-controlled drug storage, DEA licensing, CTMS and multiple EDC platforms, eConsent, cold chain storage, and specialty procedures including biopsies, PK sampling, spirometry, oscillometry, FeNO, and certified FibroScan.
Infinity Clinical Studies conducts internal medicine clinical research, ophthalmology clinical research, pain management research in San Diego, metabolic research studies in San Diego, and general medicine research across cardiology and endocrinology. The site is well positioned for renal clinical research, nephrology clinical research in San Diego, and psychiatric research studies in San Diego as the therapeutic portfolio continues to grow.
Yes. Infinity Clinical Studies is a dedicated clinical research site for sponsors and CROs, operating as part of the ECN Clinical under centralized SOPs, unified contracting, and network-wide quality standards. Sponsors and CROs benefit from a proven 85% screen to enroll rate, 91% patient retention rate, and startup timelines consistently under 4 weeks.
